Atlas Trials

A Phase II Study of BI-505 in Smoldering Multiple Myeloma

Clinical trial NCT01838369 · TERMINATED

Trial details

NCT number
NCT01838369
Sponsor
BioInvent International AB
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Smoldering Multiple Myeloma
Start date
2013-03-01
Primary completion
2014-12-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.